N/A N=265 Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board
Radiation Exposure to Operator
Primary: Operator Radiation Exposure — .65; .56 mSv
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=55 Radiation Exposure of ERCP Personnel at Different Standing Locations and Different Patient Positions.
Occupational Radiation Exposure
Primary: Effective Radiation Dose — 0.0307; 0.0192 mSv
N/A N=1,000 ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial
Radiation Exposure
Primary: Operator Exposure (OE)/Dose Area Product (DAP) (uSv[Micro-Sieverts]/mGy[Milligray]*cm2) of the Proximal Operator — 6.41; 3.51 10,000 x uSv / mGy*cm^2
N/A N=10 Dosimeter Location in Pain Physicians
RAD
Primary: Radiation Readings — 122.8; 158.8; 236.9 mREM
N/A N=170 Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
Cardiac Catheterization · Radiation Exposure
Primary: Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization — 18; 39 microsievert
N/A N=197 Radioprotective Light-weight Caps in the Interventional Cardiology Setting
Occupational Exposure to Radiation
Primary: Radiation Attenuation in Percentage (%) — 12; 91.5; 97.1 Percentage
N/A N=228 Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
Coronary Artery Disease · Chest Pain
Primary: Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging — 0.183; 0.159 gamma-H2AX foci in blood lymphocytes — p=<0.05
N/A N=20 Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Node Positive Breast Cancer
Primary: Cardiac MRI Parameters — 0; 0; 0; 0 number of patients
N/A N=6,700 Adult and Paediatric Patient Radiation Doses From Multidetector Row Computed Tomography Scans: a National Survey
Cancer
Primary: Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Head CT Examinations. — 64; 28.7 mGy
N/A N=72 Breast Displacement and CT Radiation Dose
Computed Tomography · Radiation Dosage
Primary: Skin Entrance Radiation Dose During Computed Tomography (CT) — 1775; 1325; 625; 259 mrad
N/A N=15 Human Factors Testing for OTC Use of the Erchonia® LunulaLaser
Onychomycosis
Primary: Human Factors — 15 participants
N/A N=136 X-ray Dose Reduction in Electrophysiology
Arrhythmias, Cardiac
Primary: Cumulative Dose Area Product (DAP) Value — 8.8; 15.3 Gy*cm^2 — p=<0.0001
N/A N=18 Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients
Diabetes
Primary: Dexcom G6 Accuracy Post Radiation Exposure by Clark Error Analysis (Zone A and B %) — 806; 1226; 704; 1715 Matched blood glucose readings — p=<0.05
N/A N=3 Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Cervical Cancer
Primary: Safety - Adverse Event Rate and Severity — 100; 100; 100; 33.3 percentage of participants and severity
N/A N=27 UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization
Breast Cancer
Primary: Number of Computed Tomography (CBCTs) a Participant Receives During Radiation Therapy Treatment as Quantified Via Counting the Number Used During the Setup Process. — 2…
N/A N=10 Prone Breast Irradiation for Pendulous Breasts
Breast Cancer
Primary: Dose Homogeneity 1: PTV — 9.8; 8.2; 48.2; 49.8 Gy — p=<0.05
N/A N=6 Early-Phase Safety of Proton Therapy Equipment
Malignant Glioma · Hepatocellular Carcinoma · Head and Neck Malignant Tumor
Primary: Rate and Severity of Adverse Reactions — 6 participants
N/A N=27 Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Healthy
Primary: Radlex Scale for Diagnostic Capability Ratings — 3.0388; 3.0547 units on a scale — p=0.028
N/A N=17 The Gamma Pod: A Clinical Feasibility Study Device GCC 1202: The Gamma Pod: A Clinical Feasibility Study
Breast Cancer
Primary: Demonstration of the Feasibility and Safety of Delivering a Radiation Treatment Using the GammaPod (TM) — 14 Participants
Phase 3 N=44 Proton/Photon Rt - Benign Meningiomas(P92-13)
Benign Meningioma
Primary: Progression Free Survival — 91; 91; 86; 81 percentage of participants surviving — p=0.234
N/A N=23 Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Healthy
Primary: Radlex Scale for Diagnostic Capability Ratings — 3.0610; 3.0633 units on a scale — p=0.415
N/A N=20 Image Quality and Radiation Dose in Angiography
Arteriovenous Malformations · Aneurysm · Stenosis
Primary: Image Quality. For Each Included Participant 2 Images (1 AlluraXper; 1 AlluraClarity) Were Evaluated. — 9.4; 11.9; 13.1; 14.1 Scores on a scale
N/A N=1,133 TARGeted Intraoperative radioTherapy With INTRABEAM as a Boost for Breast Cancer - A Quality Control Registry
Breast Cancer
Primary: Number of Patients With Local Recurrence — 10 participants
N/A N=74 Using Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia
Supraventricular Tachycardia
Primary: Total Fluoroscopy Time — 18.3; 7.5 minutes
N/A N=30 Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer
Head and Neck Cancer
Primary: Time Until the Maximum Oral Mucositis Measured From the Start of Radiation Treatment. — 34; 29 Days — p=0.9906
N/A N=45 Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
Prostate Cancer · Adenocarcinoma of the Prostate
Primary: Procedure Time — 30 minutes
N/A N=50 Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
Multiple Myeloma · Breast Cancer
Primary: Relative Node Detection Sensitivity — 88.5; 94.2 Percentage (%) of SLNs detected
N/A N=20 Head Stabilization of Healthy Volunteers
Healthy
Primary: Collection of Head Motion Data to be Used in Developing Head Stabilization Methods in Brain Radiation Patients — 95 % of time within tolerance
N/A N=51 X-ray Dose Reduction Study for Endovascular Interventional Radiology
Cardiovascular Disease
Primary: Image Quality — 0.96 Proportion of images rated equal/better
N/A N=44 Post Market Study Using the Xoft Axxent System
Breast Cancer
Primary: Number of Participants With Delivery of 34 Gy in 10 Fractions — 42 Participants